SEARCH

SEARCH BY CITATION

References

  • Asahara T, Kawamoto A, Masuda H (2011). Concise review: circulating endothelial progenitor cells for vascular medicine. Stem Cells 29: 16501655.
  • Baluk P, Hashizume H, McDonald DM (2005). Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev 15: 102111.
  • Banno H, Takei Y, Muramatsu T, Komori K, Kadomatsu K (2006). Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts. J Vasc Surg 44: 633641.
  • Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D (1999). Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284: 808812.
  • Boucher P, Gotthardt M, Li WP, Anderson RG, Herz J (2003). LRP: role in vascular wall integrity and protection from atherosclerosis. Science 300: 329332.
  • Broussalis E, Trinka E, Killer M, Harrer A, McCoy M, Kraus J (2012). Current therapies in ischemic stroke. Part B. Future candidates in stroke therapy and experimental studies. Drug Discov Today 17: 671684.
  • Casanovas O, Hicklin DJ, Bergers G, Hanahan D (2005). Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 8: 299309.
  • Cheng L, Huang Z, Zhou W, Wu Q, Donnola S, Liu JK et al. (2013). Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. Cell 153: 139152.
  • Choudhuri R, Zhang HT, Donnini S, Ziche M, Bicknell R (1997). An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis. Cancer Res 57: 18141819.
  • Claesson-Welsh L (2012). Blood vessels as targets in tumor therapy. Ups J Med Sci 117: 178186.
  • Cohen S, Shoshana OY, Zelman-Toister E, Maharshak N, Binsky-Ehrenreich I, Gordin M et al. (2012). The cytokine midkine and its receptor RPTPzeta regulate B cell survival in a pathway induced by CD74. J Immunol 188: 259269.
  • Crawford Y, Kasman I, Yu L, Zhong C, Wu X, Modrusan Z et al. (2009). PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell 15: 2134.
  • Dai LC, Wang X, Yao X, Lu YL, Ping JL, He JF (2007). Antisense oligonucleotide targeting midkine suppresses in vivo angiogenesis. World J Gastroenterol 13: 12081213.
  • De Palma M, Lewis CE (2013). Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 23: 277286.
  • Ferdinandy P, Schulz R, Baxter GF (2007). Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 59: 418458.
  • Ferrara N, Henzel WJ (1989). Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161: 851858.
  • Folkman J (1971). Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 11821186.
  • Fujita H, Banno H, Yamanouchi D, Kobayashi M, Yamamoto K, Komori K (2008). Pitavastatin inhibits intimal hyperplasia in rabbit vein graft. J Surg Res 148: 238243.
  • Fukui S, Kitagawa-Sakakida S, Kawamata S, Matsumiya G, Kawaguchi N, Matsuura N et al. (2008). Therapeutic effect of midkine on cardiac remodeling in infarcted rat hearts. Ann Thorac Surg 85: 562570.
  • Fukumura D, Jain RK (2007). Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem 101: 937949.
  • Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E et al. (2012). Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366: 883892.
  • Grothey A, Galanis E (2009). Targeting angiogenesis: progress with anti-VEGF treatment with large molecules. Nat Rev Clin Oncol 6: 507518.
  • Harvey BK, Shen H, Chen GJ, Yoshida Y, Wang Y (2004). Midkine and retinoic acid reduce cerebral infarction induced by middle cerebral artery ligation in rats. Neurosci Lett 369: 138141.
  • Hausenloy DJ, Erik Botker H, Condorelli G, Ferdinandy P, Garcia-Dorado D, Heusch G et al. (2013). Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 98: 727.
  • Hayashi K, Banno H, Kadomatsu K, Takei Y, Komori K, Muramatsu T (2005). Antisense oligodeoxyribonucleotide as to the growth factor midkine suppresses neointima formation induced by balloon injury. Am J Physiol Heart Circ Physiol 288: H2203H2209.
  • Horiba M, Kadomatsu K, Nakamura E, Muramatsu H, Ikematsu S, Sakuma S et al. (2000). Neointima formation in a restenosis model is suppressed in midkine-deficient mice. J Clin Invest 105: 489495.
  • Horiba M, Kadomatsu K, Yasui K, Lee JK, Takenaka H, Sumida A et al. (2006). Midkine plays a protective role against cardiac ischemia/reperfusion injury through a reduction of apoptotic reaction. Circulation 114: 17131720.
  • Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W et al. (2004). Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 23352342.
  • Ishiguro H, Horiba M, Takenaka H, Sumida A, Opthof T, Ishiguro YS et al. (2011). A single intracoronary injection of midkine reduces ischemia/reperfusion injury in Swine hearts: a novel therapeutic approach for acute coronary syndrome. Front Physiol 2: 27.
  • Ishikawa E, Ooboshi H, Kumai Y, Takada J, Nakamura K, Ago T et al. (2009). Midkine gene transfer protects against focal brain ischemia and augments neurogenesis. J Neurol Sci 285: 7884.
  • Jaipersad AS, Lip GY, Silverman S, Shantsila E (2013). The role of monocytes in angiogenesis and atherosclerosis. J Am Coll Cardiol 63: 111.
  • Kadomatsu K, Kishida S, Tsubota S (2013). The heparin-binding growth factor midkine: the biological activities and candidate receptors. J Biochem 153: 511521.
  • Kieran MW, Kalluri R, Cho YJ (2012). The VEGF pathway in cancer and disease: responses, resistance, and the path forward. Cold Spring Harb Perspect Med 2: a006593.
  • Kishida S, Mu P, Miyakawa S, Fujiwara M, Abe T, Sakamoto K et al. (2013). Midkine promotes neuroblastoma through Notch2 signaling. Cancer Res 73: 13181327.
  • Lee SH, Suh HN, Lee YJ, Seo BN, Ha JW, Han HJ (2012). Midkine prevented hypoxic injury of mouse embryonic stem cells through activation of Akt and HIF-1α via low-density lipoprotein receptor-related protein-1. J Cell Physiol 227: 17311739.
  • Lusis AJ (2000). Atherosclerosis. Nature 407: 233241.
  • Maeda N, Ichihara-Tanaka K, Kimura T, Kadomatsu K, Muramatsu T, Noda M (1999). A receptor-like protein-tyrosine phosphatase PTPzeta/RPTPbeta binds a heparin-binding growth factor midkine. Involvement of arginine 78 of midkine in the high affinity binding to PTPzeta. J Biol Chem 274: 1247412479.
  • Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M (2013). Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 229: 176185.
  • Marcelo KL, Goldie LC, Hirschi KK (2013). Regulation of endothelial cell differentiation and specification. Circ Res 112: 12721287.
  • Mashour GA, Ratner N, Khan GA, Wang HL, Martuza RL, Kurtz A (2001). The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells. Oncogene 20: 97105.
  • Moore KJ, Tabas I (2011). Macrophages in the pathogenesis of atherosclerosis. Cell 145: 341355.
  • Muramaki M, Miyake H, Hara I, Kamidono S (2003). Introduction of midkine gene into human bladder cancer cells enhances their malignant phenotype but increases their sensitivity to antiangiogenic therapy. Clin Cancer Res 9: 51525160.
  • Muramatsu H, Zou K, Sakaguchi N, Ikematsu S, Sakuma S, Muramatsu T (2000). LDL receptor-related protein as a component of the midkine receptor. Biochem Biophys Res Commun 270: 936941.
  • Muramatsu T (2010). Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases. Proc Jpn Acad Ser B Phys Biol Sci 86: 410425.
  • Murdoch C, Muthana M, Coffelt SB, Lewis CE (2008). The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8: 618631.
  • Narita H, Chen S, Komori K, Kadomatsu K (2008). Midkine is expressed by infiltrating macrophages in in-stent restenosis in hypercholesterolemic rabbits. J Vasc Surg 47: 13221329.
  • O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL (1996). The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancers. Cancer Res 56: 25152518.
  • Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R et al. (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335348.
  • Ota T, Ota K, Jono H, Fujimori H, Ueda M, Shinriki S et al. (2010). Midkine expression in malignant salivary gland tumors and its role in tumor angiogenesis. Oral Oncol 46: 657661.
  • Park C, Kim TM, Malik AB (2013). Transcriptional regulation of endothelial cell and vascular development. Circ Res 112: 13801400.
  • Poole TJ, Coffin JD (1989). Vasculogenesis and angiogenesis: two distinct morphogenetic mechanisms establish embryonic vascular pattern. J Exp Zool 251: 224231.
  • Qi M, Ikematsu S, Ichihara-Tanaka K, Sakuma S, Muramatsu T, Kadomatsu K (2000). Midkine rescues Wilms' tumor cells from cisplatin-induced apoptosis: regulation of Bcl-2 expression by midkine. J Biochem 127: 269277.
  • Qi M, Ikematsu S, Maeda N, Ichihara-Tanaka K, Sakuma S, Noda M et al. (2001). Haptotactic migration induced by midkine. Involvement of protein-tyrosine phosphatase zeta. Mitogen-activated protein kinase, and phosphatidylinositol 3-kinase. J Biol Chem 276: 1586815875.
  • Reynolds PR, Mucenski ML, Le Cras TD, Nichols WC, Whitsett JA (2004). Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J Biol Chem 279: 3712437132.
  • Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, Cenci T et al. (2010). Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468: 824828.
  • Risau W (1997). Mechanisms of angiogenesis. Nature 386: 671674.
  • Ruan M, Ji T, Wu Z, Zhou J, Zhang C (2007). Evaluation of expression of midkine in oral squamous cell carcinoma and its correlation with tumour angiogenesis. Int J Oral Maxillofac Surg 36: 159164.
  • Sakamoto K, Bu G, Chen S, Takei Y, Hibi K, Kodera Y et al. (2011). Premature ligand-receptor interaction during biosynthesis limits the production of growth factor midkine and its receptor LDL receptor-related protein 1. J Biol Chem 286: 84058413.
  • Salama RH, Muramatsu H, Zou P, Okayama M, Muramatsu T (2006). Midkine, a heparin-binding growth factor, produced by the host enhances metastasis of Lewis lung carcinoma cells. Cancer Lett 233: 1620.
  • Sato W, Kadomatsu K, Yuzawa Y, Muramatsu H, Hotta N, Matsuo S et al. (2001). Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury. J Immunol 167: 34633469.
  • Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983985.
  • Shachar I, Cohen S, Marom A, Becker-Herman S (2012). Regulation of CLL survival by hypoxia-inducible factor and its target genes. FEBS Lett 586: 29062910.
  • Shibata Y, Muramatsu T, Hirai M, Inui T, Kimura T, Saito H et al. (2002). Nuclear targeting by the growth factor midkine. Mol Cell Biol 22: 67886796.
  • Stoica GE, Kuo A, Powers C, Bowden ET, Sale EB, Riegel AT et al. (2002). Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types. J Biol Chem 277: 3599035998.
  • Sumi Y, Muramatsu H, Takei Y, Hata K, Ueda M, Muramatsu T (2002). Midkine, a heparin-binding growth factor, promotes growth and glycosaminoglycan synthesis of endothelial cells through its action on smooth muscle cells in an artificial blood vessel model. J Cell Sci 115 (Pt 13): 26592667.
  • Takada J, Ooboshi H, Ago T, Kitazono T, Yao H, Kadomatsu K et al. (2005). Postischemic gene transfer of midkine, a neurotrophic factor, protects against focal brain ischemia. Gene Ther 12: 487493.
  • Takada T, Toriyama K, Muramatsu H, Song XJ, Torii S, Muramatsu T (1997). Midkine, a retinoic acid-inducible heparin-binding cytokine in inflammatory responses: chemotactic activity to neutrophils and association with inflammatory synovitis. J Biochem 122: 453458.
  • Takenaka H, Horiba M, Ishiguro H, Sumida A, Hojo M, Usui A et al. (2009). Midkine prevents ventricular remodeling and improves long-term survival after myocardial infarction. Am J Physiol Heart Circ Physiol 296: H462H469.
  • Takubo K, Goda N, Yamada W, Iriuchishima H, Ikeda E, Kubota Y et al. (2010). Regulation of the HIF-1α level is essential for hematopoietic stem cells. Cell Stem Cell 7: 391402.
  • Tazzyman S, Lewis CE, Murdoch C (2009). Neutrophils: key mediators of tumour angiogenesis. Int J Exp Pathol 90: 222231.
  • Van Meter ME, Kim ES (2010). Bevacizumab: current updates in treatment. Curr Opin Oncol 22: 586591.
  • Weckbach LT, Groesser L, Borgolte J, Pagel JI, Pogoda F, Schymeinsky J et al. (2012). Midkine acts as proangiogenic cytokine in hypoxia-induced angiogenesis. Am J Physiol Heart Circ Physiol 303: H429H438.